Description
The U.S. Food and Drug Administration (FDA) is seeking information from small businesses to determine their capability to provide a preventive maintenance-repair (PM/R) service agreement for a Bruker 7T ScimaX mass spectrometer. The service agreement should include one planned on-site preventive maintenance visit per contract year, priority access to technical support, and engineer labor, travel, and factory-certified replacement parts for on-demand on-site corrective maintenance visits. The contractor should also provide service records and reports, and meet the minimum technical requirements specified in the notice.
* The mass spectrometer is used for matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI MSI) in the Division of Systems Biology (DSB) at the National Center for Toxicological Research (NCTR).
* The service agreement is for a base year and 2 option periods of service.
* The system is currently covered through 4/16/2026.
* The FDA is looking for small businesses with a Small Business Size Standard of $34 Million under North American Industry Classification System (NAICS) 811210.
* Interested contractors should submit capability statements via email to Tim Walbert by March 23, 2026, 2:00 PM Central Time.